Gut microbes may shape the response to anti-cancer therapy.29,30 Studies5,7,31–36 have highlighted the key role of the gut microbiota in mediating tumor responses to chemotherapeutic agents or immunotherapies targeting PD-L1 or cytotoxic T lymphocyte-associated protein 4 (CTLA-4). The gene discussed is CTLA4; the disease is neoplasm.